Skip to main content
Premium Trial:

Request an Annual Quote

BioImage to Use RNAx s RNAi-Knockdown Tool in Its Assay Technology

NEW YORK, Jan. 27 (GenomeWeb News) - RNAx yesterday said it will provide BioImage with its RNAi-knockdown technology.


The agreement will "complement" BioImage's Redistribution assay technology, and "vice versa."


"The goal of the agreement is to provide both RNAx's and BioImage's customers with both technologies from one source, the companies said in s statement.


Financial details of the agreement were not disclosed.

BioImage's Redistribution technology enables high-throughput, high-content screening on many targets of "current interest" in drug discovery, including a "range" of intracellular signaling molecules and cell-surface receptors, the companies said.


RNAx's technology, meantime, provides for automated validation of siRNAs and targets, including those for which BioImage has developed assays.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.